Peter Jakobsen - Mead Johnson CEO and President and Director
CEO
Mr. Peter Kasper Jakobsen serves as President, Chief Executive Officer, Director of the Company. Mr. Ratcliffe served, from April 2003 until his retirement in June 2007, as chief executive officer of the PO Princess International division of Carnival Corporation and plc, a global cruise company. From January 2000 to April 2003, he served as chief executive officer of PO Princess Cruises plc, a global cruise company. Mr. Ratcliffe is a director of BBA Aviation plc and Casa Pacifica Centers for Children Families since 2013.
| Age | 53 |
| Tenure | 11 years |
| Phone | 312 466 5800 |
| Web | www.meadjohnson.com |
Mead Johnson Management Efficiency
The company has Return on Asset of 0.19 % which means that on every $100 spent on assets, it made $0.19 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.7 %, implying that it generated $2.7 on every 100 dollars invested. Mead Johnson's management efficiency ratios could be used to measure how well Mead Johnson manages its routine affairs as well as how well it operates its assets and liabilities.The company has 2.99 B in debt with debt to equity (D/E) ratio of 4.69, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Mead Johnson Nutrition has a current ratio of 2.11, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Mead Johnson until it has trouble settling it off, either with new capital or with free cash flow. So, Mead Johnson's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mead Johnson Nutrition sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mead to invest in growth at high rates of return. When we think about Mead Johnson's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | CEO Age | ||
| G Callahan | GMS Inc | 60 | |
| Donald Casey | Cardinal Health | 57 | |
| Allen Grum | Rand Capital Corp | 59 | |
| Catherine Keating | Bank of New | 62 | |
| Adam Vos | Bank of New | N/A | |
| James Crowley | Bank of New | N/A | |
| Paul Camp | Bank of New | N/A | |
| Michael Callahan | GMS Inc | 63 | |
| John Turner | GMS Inc | 55 | |
| Nick Ring | Ameriprise Financial | 55 | |
| Hanneke Smits | Bank of New | 58 | |
| Michael Kaufmann | Cardinal Health | 58 | |
| Victor Crawford | Cardinal Health | 59 | |
| Roman Regelman | Bank of New | 52 | |
| William Truscott | Ameriprise Financial | 64 | |
| Brian Ruane | Bank of New | N/A | |
| Mitchell Harris | Bank of New | 64 | |
| Edward Goldthorpe | Logan Ridge Finance | 47 | |
| Francis Salla | Bank of New | 56 | |
| Stephen Mason | Cardinal Health | 52 | |
| Jon Giacomin | Cardinal Health | 52 | |
Management Performance
Mead Johnson Nutrition Leadership Team
Elected by the shareholders, the Mead Johnson's board of directors comprises two types of representatives: Mead Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mead. The board's role is to monitor Mead Johnson's management team and ensure that shareholders' interests are well served. Mead Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mead Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Golsby, Director | ||
| Charles Urbain, COO and Executive VP | ||
| Michael Sherman, Director | ||
| Michael Krestell, Independent Director | ||
| James Shiah, Chief Accounting Officer, Sr. VP and Corporate Controller | ||
| Michael Grobstein, Director | ||
| Michael Gorenstein, President CEO, Vice Chairman of the Board, Corporate Secretary | ||
| Christopher Stratton, Senior Vice President and President , Asia | ||
| Ryan Roebuck, Director | ||
| Patrick Sheller, Senior Vice President General Counsel, Secretary | ||
| Elliot Sigal, Director | ||
| Alan Friedman, Independent Director | ||
| Peter Jakobsen, CEO and President and Director | ||
| Michel Cup, CFO and Executive VP | ||
| James Rudyk, Director | ||
| Graciela Monteagudo, Senior Vice President and Presidentident for the Americas and Global Marketing | ||
| Kathy MacDonald, VP of Investor Relations | ||
| Dirk Hondmann, Chief Scientific Officer | ||
| Howard Bernick, Independent Director | ||
| James Jobe, Sr. VP of Technical Operations | ||
| Elliott Sigal, Director | ||
| Peter Ratcliffe, Independent Director | ||
| Anna Catalano, Independent Director | ||
| Jason Adler, Director | ||
| Robert Singer, Lead Independent Director | ||
| Charles Sigal, Director | ||
| William Hilson, CFO | ||
| Ian Ormesher, Senior Vice President- Global Human Resources | ||
| James Cornelius, Non-Executive Chairman of the Board | ||
| Steven Altschuler, Independent Director | ||
| Celeste Clark, Independent Director | ||
| Kimberly Casiano, Independent Director |
Mead Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mead Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.7 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 23.08 % | |||
| Current Valuation | 16.04 B | |||
| Shares Outstanding | 183.64 M | |||
| Shares Owned By Insiders | 0.21 % | |||
| Shares Owned By Institutions | 98.70 % | |||
| Number Of Shares Shorted | 3.64 M | |||
| Price To Earning | 28.27 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mead Johnson in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mead Johnson's short interest history, or implied volatility extrapolated from Mead Johnson options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Mead Stock
If you are still planning to invest in Mead Johnson Nutrition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mead Johnson's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |